- Advertisement -
Saturday, March 25, 2023
Home Article Pharma & Biotech

Pharma & Biotech

Powering Diverse and Inclusive Clinical Trials

The Food and Drug Administration (FDA) will soon require clinical trial sponsors to submit a plan for improving diversity among clinical trial participants. While...

The power of novel excipients in 505(b)(2) products

The FDA 505(b)(2) regulatory pathway for drug approval, which allows applicants to use existing safety data as evidence, continues to grow in popularity. Innovators...

Decentralized Centricity in Clinical Trials. What is it. How to get there.

The notion that a quality clinical trial should be conducted in highly specialized and experienced study centers with tight oversight of patients is becoming...

Is the Burden of Clinical Trial Technology Sabotaging Sites? A Call for a Universal Solution

The ongoing digital revolution in clinical trials has created a daunting new task for the sites conducting the research: managing all the technology required...

Shifting the Balance to Hybrid – Maximizing Patient Experience and Data Quality

Clinical trial sponsors are constantly trying to balance different goals and demands. Ensuring data quality is key, yet clients also seek to recruit diverse...

Health equity movement fueled by digital innovation and disruption

It is not a revelation to anyone that healthcare and clinical trials have a very big problem when it comes to diversity, equity, and...

The market for outsourced biologics manufacturing is expected to reach $34.1 billion by the end of 2033

Contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) are biotechnology firms that offer a variety of services to pharmaceutical and biotechnology...

Medical professionalism in a changing world

Human life was transitory before the discovery of modern medicine. Unseen risks in the form of sickness and medical disorders abound in the environment....
- Advertisement -

Editor Picks

Course Director BSc (Hons) Diagnostic Radiography and Imaging

Until relatively recently, vision had been considered an attribute of animates only.  The ImageNet challenge provided a showcase for artificial intelligence (AI) tools for...

Powering Diverse and Inclusive Clinical Trials

The Food and Drug Administration (FDA) will soon require clinical trial sponsors to submit a plan for improving diversity among clinical trial participants. While...

Improving antibiotic use with novel diagnostic technologies: Challenges Ahead

Antibiotics have revolutionized human medicine in the twentieth century. Deadly diseases such as streptococcal pneumonia or gangrene became curable, and also other advances of...

The power of novel excipients in 505(b)(2) products

The FDA 505(b)(2) regulatory pathway for drug approval, which allows applicants to use existing safety data as evidence, continues to grow in popularity. Innovators...

Where Is Pharma Headed in 2023?

Learn 10 disruptive trends shaping the future of life science manufacturing, and how you can adapt to stay on target and ahead of the...

Industry Pros Come Together to Develop ASTM Protocols

A powerhouse group was created with the goal of getting ASTM to adopt standards for SIJ fusion devices. Accurate, repeatable, and reproducible—that’s the mantra we’ve...